2010
DOI: 10.1016/j.jaac.2009.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Trends in Antipsychotic Drug Use by Very Young, Privately Insured Children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
61
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 119 publications
(67 citation statements)
references
References 41 publications
6
61
0
Order By: Relevance
“…A large-scale study of Medicaid-eligible U.S. children indicated that services used change with age: as children got older psychotropic medication increased, while use of speech, occupational, and physical therapies decreased (Cidav, Lawer, Marcus, & Mandell, 2013). Psychopharmacological treatments are consistently reported as more commonly used among older children with ASD (Aman et al, 2003;Goin-Kochel et al, 2007), although drug treatments are increasingly offered to younger and younger children (Olfson, Crystal, Huang, & Gerhard, 2010). On the other hand, special diets (e.g., gluten-free and/or casein-free) and behavioral/educational treatments may more often be pursued for younger age groups (Goin-Kochel et al, 2007).…”
Section: Child Age and Treatment Selectionmentioning
confidence: 99%
“…A large-scale study of Medicaid-eligible U.S. children indicated that services used change with age: as children got older psychotropic medication increased, while use of speech, occupational, and physical therapies decreased (Cidav, Lawer, Marcus, & Mandell, 2013). Psychopharmacological treatments are consistently reported as more commonly used among older children with ASD (Aman et al, 2003;Goin-Kochel et al, 2007), although drug treatments are increasingly offered to younger and younger children (Olfson, Crystal, Huang, & Gerhard, 2010). On the other hand, special diets (e.g., gluten-free and/or casein-free) and behavioral/educational treatments may more often be pursued for younger age groups (Goin-Kochel et al, 2007).…”
Section: Child Age and Treatment Selectionmentioning
confidence: 99%
“…In the United States, children as young as 4 or 5 years are being treated with drugs, 17 using criteria for diagnosis that would not be accepted in the NHS. Thus, increasing numbers of children and young people are taking antipsychotics, 18 which are associated with serious adverse events, including increased prolactin levels, rapid weight gain, and increased risk of diabetes. 12 The previous NICE guideline rejected the extension of bipolar disorder into childhood and suggested that clinicians apply stricter criteria to adolescents, 19 but the diagnosis and treatment of children and adolescents has continued, mostly in the US.…”
Section: Overcoming Barriersmentioning
confidence: 99%
“…At the same time, there was a steep rise in antipsychotic prescriptions in the USA,11 raising concerns that children were overdiagnosed and unduly prescribed potentially harmful medication. The observed increase is unlikely due to a genuine increase in the prevalence of the disorder, but rather reflect changes in diagnostic practice.…”
Section: Bipolar Controversy: Irritability and Disruptive Mood Dysregmentioning
confidence: 99%